Patents Assigned to Bio-K + International Inc.
-
Publication number: 20190038683Abstract: The present invention concerns a lactic composition useful for the prevention or treatment of diarrhea such as antibiotic associated diarrhea or “tourists.” The composition according to the invention contains at least a bacterial strain selected from the group consisting of Lactobacillus acidophilus, Lactobacillus acidophilus I-1492, Lactobacillus casei and a mixture of thereof.Type: ApplicationFiled: October 9, 2018Publication date: February 7, 2019Applicant: BIO-K PLUS INTERNATIONAL, INC.Inventor: Francois-Marie Luquet
-
Patent number: 10124026Abstract: The present invention concerns a lactic composition useful for the prevention or treatment of diarrhea such as antibiotic associated diarrhea or “tourists.” The composition according to the invention contains at least a bacterial strain selected from the group consisting of Lactobacillus acidophilus, Lactobacillus acidophilus I-1492, Lactobacillus casei and a mixture of thereof.Type: GrantFiled: May 17, 2017Date of Patent: November 13, 2018Assignee: BIO-K PLUS INTERNATIONAL, INC.Inventor: Francois-Marie Luquet
-
Patent number: 8926960Abstract: The present invention relates to methicillin-resistant Staphylococcus aureus growth inhibition by lactic acid bacterium strains. More specifically it is directed to the use of lactic acid bacterium strains, compositions comprising lactic acid bacterium strains, methods of use and kits thereof to inhibit the growth of methicillin-resistant Staphylococcus aureus. This invention more specifically relates to the inhibitory effect of lactic acid bacterium strains Lactobacillus acidophilus and Lactobacillus caseion methicillin-resistant Staphylococcus aureus.Type: GrantFiled: June 14, 2010Date of Patent: January 6, 2015Assignee: Bio-K Plus International Inc.Inventors: Wanda Smoragiewicz, Mari Bazo, Marcia Ruiz, François-Marie Luquet, Antoni Wysocki
-
Publication number: 20130302298Abstract: The present invention broadly relates to the use of probiotics for the treatment and prevention of dermatitis. More particularly, the present invention relates to the use of a composition comprising Lactobacillus acidophilus strain I-1492 deposited at the CNCM, a Lactobacillus casei LBC80R® strain and a carrier for treating or preventing hand dermatitis.Type: ApplicationFiled: November 29, 2011Publication date: November 14, 2013Applicant: BIO-K PLUS INTERNATIONAL INC.Inventors: Claude Chevalier, Serge Carriere
-
Publication number: 20120107289Abstract: The present invention concerns a lactic composition useful for the prevention or treatment of diarrhea such as antibiotic associated diarrhea or “tourista.” The composition according to the invention contains at least a bacterial strain selected from the group consisting of Lactobacillus acidophilus, Lactobacillus acidophilus I-1492, Lactobacillus casei and a mixture of thereof.Type: ApplicationFiled: May 17, 2011Publication date: May 3, 2012Applicant: BIO-K PLUS INTERNATIONAL, INC.Inventor: Francois-Marie LUQUET
-
Publication number: 20110195057Abstract: The present invention relates to methicillin-resistant Staphylococcus aureus growth inhibition by lactic acid bacterium strains. More specifically it is directed to the use of lactic acid bacterium strains, compositions comprising lactic acid bacterium strains, methods of use and kits thereof to inhibit the growth of methicillin-resistant Staphylococcus aureus. This invention more specifically relates to the inhibitory effect of lactic acid bacterium strains Lactobacillus acidophilus and Lactobacillus caseion methicillin-resistant Staphylococcus aureus.Type: ApplicationFiled: June 14, 2010Publication date: August 11, 2011Applicant: BIO-K PLUS INTERNATIONAL, INC.Inventors: Wanda Smoragiewicz, Barbara Karska-Wysocki, Mari Bazo, Marcia Ruiz, François-Marie Luquet, Antoni Wysocki
-
Publication number: 20110159131Abstract: A lactic composition containing at least a bacterial strain selected from the group consisting of Lactobacillus acidophilus, Lactobacillus casei and a mixture of Lactobacillus acidophilus and Lactobacillus casei, and a whole broth of the bacterial strain or the mixture of the bacterial strains, is useful for the prevention or treatment of disorders which are angiogenesis dependant. Both the lactic composition and its supernatant can be used for prevention or treatment of angiogenesis dependant disorders. The supernatant of the lactic composition exhibits antiangiogenic properties.Type: ApplicationFiled: December 2, 2010Publication date: June 30, 2011Applicant: BIO-K PLUS INTERNATIONAL, INC.Inventors: Richard BELIVEAU, François-Marie LUQUET
-
Patent number: 7887794Abstract: The invention concerns the isolation of novel properties of lactic acid bacteria stains. Said novel properties are advantageously useful for preventing and treating cancer. More particularly, the invention concerns the use of lactic acid bacteria to facilitate induction of cell apoptosis of a cancer. The invention also concerns the use of lactic acid bacterial strains, such as Lactobacillus acidophilus and Lactobacillus casei in methods and compositions for preventing and treating cancer, in particular colon cancer.Type: GrantFiled: November 27, 2002Date of Patent: February 15, 2011Assignee: Bio-K Plus International, Inc.Inventors: François-Marie Luquet, Cindy Baldwin, Monique Lacroix
-
Patent number: 7862809Abstract: A lactic composition containing at least a bacterial strain selected from the group consisting of Lactobacillus acidophilus, Lactobacillus casei and a mixture of Lactobacillus acidophilus and Lactobacillus casei, and a whole broth of the bacterial strain or the mixture of the bacterial strains, is useful for the prevention or treatment of disorders which are angiogenesis dependant. Both the lactic composition and its supernatant can be used for prevention or treatment of angiogenesis dependant disorders. The supernatant of the lactic composition exhibits antiangiogenic properties.Type: GrantFiled: November 15, 2004Date of Patent: January 4, 2011Assignee: Bio-K Plus International, Inc.Inventors: Richard Beliveau, Francois-Marie Luquet
-
Publication number: 20070086991Abstract: A lactic composition containing at least a bacterial strain selected from the group consisting of Lactobacillus acidophilus, Lactobacillus casei and a mixture of Lactobacillus acidophilus and Lactobacillus casei, and a whole broth of the bacterial strain or the mixture of the bacterial strains, is useful for the prevention or treatment of disorders which are angiogenesis dependant. Both the lactic composition and its supernatant can be used for prevention or treatment of angiogenesis dependant disorders. The supernatant of the lactic composition exhibits antiangiogenic properties.Type: ApplicationFiled: November 15, 2004Publication date: April 19, 2007Applicant: BIO-K PLUS INTERNATIONAL, INC.Inventors: Richard Beliveau, Francois-Marie Luquet
-
Publication number: 20050208033Abstract: The invention concerns the isolation of novel properties of lactic acid bacteria stains. Said novel properties are advantageously useful for preventing and treating cancer. More particularly, the invention concerns the use of lactic acid bacteria to facilitate induction of cell apoptosis of a cancer. The invention also concerns the use of lactic acid bacterial strains, such as Lactobacillus acidophilus and Lactobacillus casei in methods and compositions for preventing and treating cancer, in particular colon cancer.Type: ApplicationFiled: November 27, 2002Publication date: September 22, 2005Applicant: BIO-K PLUS INTERNATIONAL INC.Inventors: Francois-Marie Luquet, Cindy Bladwin, Monique Lacroix
-
Patent number: 6607905Abstract: The purified strain of Lactobacillus acidophilus CNCM/I-1492 (L.a. 1492) when administered alone or in combination with another Lactobacillus acidophilus (L.a.) strain and Lactobacillus casei (L.c.) strain, has a beneficial effect on the cholesterol blood level in mammals. It also strenghtens the immune system, facilitates the absorption of nutrients and stimulates the intestinal flora. Such strains also neutralize side effects caused by antibiotics. The invention concerns the specific strain L.a. I-1492, a ferment comprising L.a. I-1492, L.a. and L.c. strains, a dairy product obtained by this ferment and a method of manufacturing the dairy product.Type: GrantFiled: May 28, 1999Date of Patent: August 19, 2003Assignee: Bio-K + International Inc.Inventor: François-Marie Luquet